• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Quantitative and Cost Evaluation of Three Antiglaucoma Beta-Blocker Agents: Timoptic-XE7 versus Two Generic Levobunolol Products

Publication
Article
The American Journal of Managed CareFebruary 1996
Volume 2
Issue 2

Related Videos
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.